Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 24
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Mol Genet Metab ; 121(2): 170-179, 2017 06.
Artigo em Inglês | MEDLINE | ID: mdl-28476546

RESUMO

BACKGROUND: Infantile gangliosidoses include GM1 gangliosidosis and GM2 gangliosidosis (Tay-Sachs disease, Sandhoff disease). To date, natural history studies in infantile GM2 (iGM2) have been retrospective and conducted through surveys. Compared to iGM2, there is even less natural history information available on infantile GM1 disease (iGM1). There are no approved treatments for infantile gangliosidoses. Substrate reduction therapy using miglustat has been tried, but is limited by gastrointestinal side effects. Development of effective treatments will require identification of meaningful outcomes in the setting of rapidly progressive and fatal diseases. OBJECTIVES: This study aimed to establish a timeline of clinical changes occurring in infantile gangliosidoses, prospectively, to: 1) characterize the natural history of these diseases; 2) improve planning of clinical care; and 3) identify meaningful future treatment outcome measures. METHODS: Patients were evaluated prospectively through ongoing clinical care. RESULTS: Twenty-three patients were evaluated: 8 infantile GM1, 9 infantile Tay-Sachs disease, 6 infantile Sandhoff disease. Common patterns of clinical change included: hypotonia before 6months of age; severe motor skill impairment within first year of life; seizures; dysphagia and feeding-tube placement before 18months of age. Neurodevelopmental testing scores reached the floor of the testing scale by 20 to 28months of age. Vertebral beaking, kyphosis, and scoliosis were unique to patients with infantile GM1. Chest physiotherapy was associated with increased survival in iGM1 (p=0.0056). Miglustat combined with a low-carbohydrate ketogenic diet (the Syner-G regimen) in patients who received a feeding-tube was associated with increased survival in infantile GM1 (p=0.025). CONCLUSIONS: This is the first prospective study of the natural history of infantile gangliosidoses and the very first natural history of infantile GM1. The homogeneity of the infantile gangliosidoses phenotype as demonstrated by the clinical events timeline in this study provides promising secondary outcome measure candidates. This study indicates that overall survival is a meaningful primary outcome measure for future clinical trials due to reliable timing and early occurrence of this event. Combination therapy approaches, instead of monotherapy approaches, will likely be the best way to optimize clinical outcomes. Combination therapy approaches include palliative therapies (e.g., chest physiotherapy) along with treatments that address the underlying disease pathology (e.g. miglustat or future gene therapies).


Assuntos
Gangliosidoses GM2/fisiopatologia , Gangliosidoses/fisiopatologia , Gangliosidoses/terapia , Gangliosidose GM1/fisiopatologia , 1-Desoxinojirimicina/efeitos adversos , 1-Desoxinojirimicina/análogos & derivados , 1-Desoxinojirimicina/uso terapêutico , Dieta Cetogênica , Dissacaridases/antagonistas & inibidores , Feminino , Gangliosidoses/complicações , Gangliosidoses GM2/terapia , Gangliosidose GM1/terapia , Inibidores de Glicosídeo Hidrolases/efeitos adversos , Inibidores de Glicosídeo Hidrolases/uso terapêutico , Humanos , Lactente , Masculino , Estudos Prospectivos , Estudos Retrospectivos
5.
Proc Natl Acad Sci U S A ; 94(15): 8138-43, 1997 Jul 22.
Artigo em Inglês | MEDLINE | ID: mdl-9223328

RESUMO

The GM2 activator deficiency (also known as the AB variant), Tay-Sachs disease, and Sandhoff disease are the major forms of the GM2 gangliosidoses, disorders caused by defective degradation of GM2 ganglioside. Tay-Sachs and Sandhoff diseases are caused by mutations in the genes (HEXA and HEXB) encoding the subunits of beta-hexosaminidase A. The GM2 activator deficiency is caused by mutations in the GM2A gene encoding the GM2 activator protein. For degradation of GM2 ganglioside by beta-hexosamindase A, the GM2 activator protein must participate by forming a soluble complex with the ganglioside. In each of the disorders, GM2 ganglioside and related lipids accumulate to pathologic levels in neuronal lysosomes, resulting in clinically similar disorders with an onset in the first year of life, progressive neurodegeneration, and death by early childhood. We previously have described mouse models of Tay-Sachs (Hexa -/-) and Sandhoff (Hexb -/-) diseases with vastly different clinical phenotypes. The Hexa -/- mice were asymptomatic whereas the Hexb -/- mice were severely affected. Through gene disruption in embryonic stem cells we now have established a mouse model of the GM2 activator deficiency that manifests an intermediate phenotype. The Gm2a -/- mice demonstrated neuronal storage but only in restricted regions of the brain (piriform, entorhinal cortex, amygdala, and hypothalamic nuclei) reminiscent of the asymptomatic Tay-Sachs model mice. However, unlike the Tay-Sachs mice, the Gm2a -/- mice displayed significant storage in the cerebellum and defects in balance and coordination. The abnormal ganglioside storage in the Gm2a -/- mice consisted of GM2 with a low amount of GA2. The results demonstrate that the activator protein is required for GM2 degradation and also may indicate a role for the GM2 activator in GA2 degradation.


Assuntos
Cerebelo/patologia , Gangliosidoses/patologia , Atividade Motora , Animais , Modelos Animais de Doenças , Gangliosidoses/enzimologia , Gangliosidoses/genética , Gangliosidoses/fisiopatologia , Vetores Genéticos , Glicolipídeos/metabolismo , Hexosaminidase A , Hexosaminidase B , Homozigoto , Camundongos , Neurônios/metabolismo , Neurônios/patologia , Fenótipo , beta-N-Acetil-Hexosaminidases/metabolismo
6.
J Med Genet ; 33(4): 341-3, 1996 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-8730294

RESUMO

Mutations in the hexosaminidase A gene (HEXA) causing the B1 variant of GM2-gangliosidosis result in the presence of a mutant enzyme protein with a catalytically defective alpha subunit. A rare and panethnically distributed mutation, transition G533A (Arg178His), is known to be a common allele among Portuguese patients with the subacute phenotype. We now report the presence of an Arg178His allele in three Portuguese sibs with a chronic form of the disease, who carry the transition G755A (Arg252His) on the second allele. This novel mutation is the first B1 allele to be associated with an adult phenotype.


Assuntos
Gangliosidoses/genética , beta-N-Acetil-Hexosaminidases/genética , Adulto , Alelos , Sequência de Aminoácidos/genética , Arginina/genética , Análise Mutacional de DNA , Gangliosídeo G(M2) , Gangliosidoses/enzimologia , Gangliosidoses/fisiopatologia , Hexosaminidase A , Histidina/genética , Humanos , Dados de Sequência Molecular , Linhagem , Fenótipo , Reação em Cadeia da Polimerase , Polimorfismo Conformacional de Fita Simples , Portugal
7.
Avian Dis ; 39(2): 292-303, 1995.
Artigo em Inglês | MEDLINE | ID: mdl-7677649

RESUMO

A 6-month-old female emu (Dromaius novaehollandiae) died following acute central nervous system signs. Hematoxylin-and-eosin-stained sections revealed that neurons of the brain were distended with nonstaining 1-to-2-microns vacuoles. Ultrastructural examination of the affected neurons revealed numerous membranous cytoplasmic bodies (MCBs) similar in appearance to the MCBs seen in mammalian gangliosidoses. A full sibling of this emu was donated for study. This 7-month-old female emu was stunted compared with hatchmates. Neurologic examination revealed hypermetric gait, persistent head tremor, and mild ataxia. No gross lesions were evident at postmortem. Histopathologic and electron microscopic findings were similar to those in the index case in that swollen, pale neurons were present in the cerebrum, pons, medulla, cerebellum, spinal cord, spinal ganglia, autonomic ganglia, myenteric plexus, and ganglion cell layer of the retina. Analysis of brain gangliosides of the affected 7-month-old emu revealed 14- and 25-fold increases of GM1 and GM3 gangliosides, respectively, compared with control emus. The total brain ganglioside sialic acids were, on a wet weight basis, 519 micrograms/g (control A), 658 micrograms/g (control B), and 1800 micrograms/g (affected emu). The familial association seen with this condition suggests that emus are affected by an inherited disorder similar to mammalian gangliosidoses.


Assuntos
Doenças das Aves/fisiopatologia , Gangliosidoses/veterinária , Animais , Doenças das Aves/enzimologia , Doenças das Aves/patologia , Encéfalo/enzimologia , Encéfalo/ultraestrutura , Cromatografia em Camada Fina/veterinária , Feminino , Gangliosídeos/metabolismo , Gangliosidoses/enzimologia , Gangliosidoses/patologia , Gangliosidoses/fisiopatologia , Microscopia Eletrônica/veterinária
8.
J Neurol Neurosurg Psychiatry ; 54(12): 1112-3, 1991 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-1838393

RESUMO

A 42 year old man presented with a slowly progressive gait disturbance, generalised weakness, dysarthria, clumsiness and tremor of his hands, and involuntary jerks. Hexosaminidase A activity in plasma, leucocytes and fibroblasts was considerably reduced, establishing the diagnosis of GM2 gangliosidosis. Clinical examination showed two previously unreported features, a clinically evident sensory neuropathy and internuclear ophthalmoplegia.


Assuntos
Doenças Neuromusculares/fisiopatologia , Oftalmoplegia/fisiopatologia , beta-N-Acetil-Hexosaminidases/deficiência , Adulto , Gangliosidoses/enzimologia , Gangliosidoses/patologia , Gangliosidoses/fisiopatologia , Hexosaminidase A , Humanos , Masculino , Condução Nervosa/fisiologia , Doenças Neuromusculares/enzimologia , Doenças Neuromusculares/patologia , Oftalmoplegia/enzimologia , Nervo Sural/patologia , Síndrome
9.
Brain Res Dev Brain Res ; 51(2): 167-78, 1990 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-2108821

RESUMO

The incidence of cortical pyramidal neurons displaying meganeurites or enlarged axon hillocks with ectopic spines and neurites was evaluated developmentally using feline models of GM1 and GM2 gangliosidosis. Results of these studies demonstrated that the onset of ectopic neurite growth occurred after the elaboration of dendrites on cortical pyramidal neurons, and that the time of onset of this renewed dendritogenesis was similar in the two diseases. Initiation and growth of ectopic neurites also correlated in a general way with onset and progression of clinical deterioration in both diseases. In GM1 gangliosidosis there was a greater tendency toward formation of meganeurites, whereas in cats with GM2 gangliosidosis the growth of ectopic axon hillock neurites without meganeurites predominated. At end-stage disease in GM2 gangliosidosis, nearly 90% of pyramidal cells displayed some degree of axon hillock neurite growth as opposed to less than half this number for GM1 gangliosidosis cats at the same age. These data are consistent with the hypothesis that there are two separate driving forces behind these somadendritic abnormalities of pyramidal neurons in the gangliosidoses. Excessive intraneuronal accumulation of storage vacuoles accounts for the formation of meganeurites, whereas some type of intrinsic metabolic defect results in axon hillock neurite growth which in turn offers new surface area for synaptic input. Currently available data indicate that GM2 or GM3 ganglioside, or a closely related metabolic product other than GM1 ganglioside, may be primarily associated with the growth of ectopic dendritic processes on morphologically mature neurons in storage diseases.


Assuntos
Córtex Cerebral/patologia , Dendritos/patologia , Gangliosidoses/patologia , Animais , Gatos , Córtex Cerebral/crescimento & desenvolvimento , Córtex Cerebral/fisiopatologia , Gangliosidoses/fisiopatologia
11.
Brain Res ; 339(2): 329-36, 1985 Jul 29.
Artigo em Inglês | MEDLINE | ID: mdl-2992703

RESUMO

Postsynaptic potentials evoked by ventrolateral thalamic stimulation were recorded intracellularly from neurons in the precruciate cortex of GM1 mutants with HRP- or LY-loaded microelectrodes. Ganglioside-laden pyramidal neurons exhibiting somal distention and/or meganeurite formation were found to respond to thalamic stimulation with short duration IPSPs. Evoked EPSPs were recorded from two morphologically characterized large basket intrinsic neurons which deployed extensive intracortical axonal arborizations. These findings point to the preservation of intracortical inhibitory networks in the feline model of GM1 gangliosidosis, and to the possibility of abnormal integration of somadendritic inputs in ganglioside-laden pyramidal neurons.


Assuntos
Gangliosidoses/fisiopatologia , Córtex Motor/fisiopatologia , Núcleos Talâmicos/fisiopatologia , Animais , Gatos , Potenciais Evocados , Gangliosídeo G(M1) , Gangliosidoses/patologia , Humanos , Córtex Motor/patologia , Inibição Neural , Sinapses/fisiologia , Transmissão Sináptica
12.
Neurology ; 35(6): 875-80, 1985 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-3923388

RESUMO

We studied a family with adult GM1-gangliosidosis. The proband, aged 38, had slowly progressive extrapyramidal signs with prominent dystonia, starting at about age 19. Two other patients, aged 45 and 43, had occasional slight dystonia, but led normal social lives because of mildness of their symptoms. Rectal biopsy of the proband showed histiocytic infiltration and membranous cytoplasmic bodies in the autonomic neurons. This family shows the clinical heterogeneity in adult GM1-gangliosidosis.


Assuntos
Gangliosídeo G(M1) , Gangliosídeos , Gangliosidoses/fisiopatologia , Reto/patologia , Adulto , Biópsia , Encéfalo/diagnóstico por imagem , Cromatografia em Camada Fina , Distonia/patologia , Feminino , Gangliosidoses/complicações , Gangliosidoses/genética , Gangliosidoses/patologia , Histiócitos/ultraestrutura , Humanos , Masculino , Microscopia Eletrônica , Pessoa de Meia-Idade , Oligossacarídeos/urina , Linhagem , Plexo Submucoso/ultraestrutura , Tomografia Computadorizada por Raios X
13.
Neuropediatrics ; 15 Suppl: 74-84, 1984 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-6100798

RESUMO

Neurophysiological studies (EEG, ERG, VEP and BAEP) have been carried out on a total of fifty-four patients (fourty-five GM2 and nine GM1 gangliosidosis) at various stages of the disease process. In infantile GM2 gangliosidosis, the EEG was midly abnormal from an early age but by the age of one year there was a rapid and progressive deterioration. EEG changes in late onset GM2 gangliosidosis were very variable and unrelated to age or enzyme defect. In both Type 1 and Type 2 GM1 gangliosidosis there was a progressive deterioration of the EEG. Paroxysmal features were not prominent in any of the gangliosidoses, despite the occurrence of seizures. The ERG remained normal in both GM2 and GM1 patients. In the infantile GM2 patients there was progressive loss of the VEP between nine and fifteen months of age but the timing of VEP changes were more variable in all the other groups. Evidence of brainstem dysfunction was found in one of the two TSD patients tested. The combined neurophysiological features appear to be characteristic for each group of gangliosidosis and differ from other neurometabolic disorders of childhood.


Assuntos
Gangliosídeo G(M1)/metabolismo , Gangliosídeo G(M2)/metabolismo , Gangliosídeos/metabolismo , Gangliosidoses/fisiopatologia , Doença de Sandhoff/fisiopatologia , Transmissão Sináptica , Doença de Tay-Sachs/fisiopatologia , Nível de Alerta/fisiologia , Encéfalo/fisiopatologia , Criança , Pré-Escolar , Eletroencefalografia , Eletrorretinografia , Potenciais Evocados , Humanos , Lactente
15.
Acta Neurol Scand ; 70(1): 1-11, 1984 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-6147947

RESUMO

An increasing focus on the mechanism of synaptic neurochemistry in pediatric neurology, may lead to a better understanding of the pathophysiology of many disorders and result in a more rational approach to their pharmacotherapy. With the burgeoning list of putative neurotransmitters in brain, and the growing evidence of co-localization of many of these neurotransmitters, chemical neurotransmission likely involves a higher degree of complexity than appreciated heretofore. The potential role of neurotransmitter dysfunction in the pathophysiology of neurologic and behavior disorders of children, should not be considered as restricted to those disorders that involve selective neuronal loss, but may encompass a much wider spectrum of syndromes due to metabolic abnormalities, as well as disturbances of the finer features of chemical neurotransmission.


Assuntos
Sistema Nervoso Central/crescimento & desenvolvimento , Transtornos Mentais/fisiopatologia , Doenças do Sistema Nervoso/fisiopatologia , Neurotransmissores/fisiologia , Vias Aferentes/crescimento & desenvolvimento , Animais , Dano Encefálico Crônico/induzido quimicamente , Dano Encefálico Crônico/embriologia , Dano Encefálico Crônico/fisiopatologia , Gatos , Córtex Cerebral/crescimento & desenvolvimento , Fenômenos Químicos , Química , Criança , Pré-Escolar , Gangliosídeo G(M1) , Gangliosidoses/fisiopatologia , Humanos , Acetato de Metilazoximetanol , Tecido Nervoso/metabolismo , Neurônios/fisiologia , Ratos , Sistema Nervoso Simpático/crescimento & desenvolvimento , Sistema Nervoso Simpático/fisiopatologia , Sinapses/fisiologia , Síndrome de Tourette/fisiopatologia , Ácido gama-Aminobutírico/fisiologia
16.
J Psychiatr Res ; 18(4): 501-12, 1984.
Artigo em Inglês | MEDLINE | ID: mdl-6150995

RESUMO

Recent years have witnessed considerable change in the conceptualization of the pathophysiology of the cognitive impairments in dementing disorders, as a result of synaptic neurochemical analyses. Profound reductions in the forebrain cholinergic projections occur in Alzheimer's disease. In GM1 gangliosidosis, variable alterations in neurotransmitter related processes that are located in synaptic membranes have been described. Exploitation of animal models of human disorders resulting in dementia may further clarify the dynamic alterations in the biochemical processes required for effective neurotransmission in cortex.


Assuntos
Encéfalo/fisiopatologia , Demência/fisiopatologia , Neurotransmissores/fisiologia , Transmissão Sináptica , Doença de Alzheimer/fisiopatologia , Animais , Gatos , Córtex Cerebral/anormalidades , Córtex Cerebral/fisiopatologia , Fibras Colinérgicas/fisiologia , Modelos Animais de Doenças , Dopamina/fisiologia , Gangliosídeo G(M1) , Gangliosidoses/fisiopatologia , Glutamatos/fisiologia , Ácido Glutâmico , Humanos , Norepinefrina/fisiologia , Ratos , Serotonina/fisiologia , Ácido gama-Aminobutírico/fisiologia
17.
Dev Neurosci ; 6(1): 58-71, 1983.
Artigo em Inglês | MEDLINE | ID: mdl-6421563

RESUMO

A theoretical discussion on the correlation between residual enzyme activities in inherited enzyme deficiencies and the development of neurological disorders is presented, based on the kinetic analysis of a simple model. Several metabolic diseases with wide spectra of clinical presentation are discussed in relation to this model.


Assuntos
Enzimas/deficiência , Doenças do Sistema Nervoso/fisiopatologia , Enzimas/metabolismo , Galactosemias/fisiopatologia , Gangliosidoses/fisiopatologia , Doença de Gaucher/fisiopatologia , Humanos , Cinética , Leucodistrofia Metacromática/fisiopatologia , Erros Inatos do Metabolismo/fisiopatologia , Mucopolissacaridose I/fisiopatologia , Mucopolissacaridose IV/fisiopatologia , Doenças do Sistema Nervoso/enzimologia , Doenças do Sistema Nervoso/etiologia , Doenças de Niemann-Pick/fisiopatologia
18.
Ital J Neurol Sci ; 3(3): 201-6, 1982 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-6819251

RESUMO

Neurophysiological studies (EEG, ERG, VEP) have been carried out on 8 children with proven GM1 gangliosidosis (3 of Type I and 5 of Type II). All the EEGs were abnormal showing an increasing amount of irregular slow activity as the disease progressed. Around 2 to 3 years of age, Type II patients often showed a fluctuating 4-5 c/s rhythmic activity especially prominent in the temporal regions. Paroxysmal activity was not a conspicuous feature in any of the patients. The ERG was normal in all cases but the VEP was variably altered. The EEG/ERG/VEP findings in GM1 gangliosidosis differ from those seen in most other neurometabolic disorders of childhood.


Assuntos
Gangliosidoses/fisiopatologia , Sistema Nervoso/fisiopatologia , Criança , Pré-Escolar , Eletroencefalografia , Eletrorretinografia , Potenciais Evocados Visuais , Feminino , Gangliosidoses/classificação , Humanos , Lactente , Masculino , Fatores de Tempo
20.
Electroencephalogr Clin Neurophysiol ; 49(5-6): 437-45, 1980 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-6158425

RESUMO

Spinal and cerebral somatosensory evoked potentials to peroneal nerve and median nerve stimulation were recorded in 17 children with CNS degenerative disease and compared with similar potentials obtained in a group of age-matched normal control subjects. Spinal potentials were increased in duration over caudal cord segments and were poorly defined or absent over the rostral cord in some patients. In 12 patients the conduction velocity of the spinal response was slow over spinal cord segments. However, conduction velocity over peripheral nerve and cauda equina was normal in all patients. The scalp recorded evoked potentials to both median and peroneal nerve stimulation which arise in neural structures rostral to the brain stem were absent in 14 patients. Cerebral responses and certain spinal potentials were greatly increased in amplitude in one patient with myoclonus. This study demonstrates that these methods permit an evaluation of the entire neuraxis from peripheral nerve to cerebral cortex and that they may be helpful in the evaluation of patients with diffuse or multifocal disease of the nervous system.


Assuntos
Encéfalo/fisiopatologia , Doenças do Sistema Nervoso Central/fisiopatologia , Medula Espinal/fisiopatologia , Criança , Pré-Escolar , Estimulação Elétrica , Potenciais Evocados , Gangliosidoses/fisiopatologia , Humanos , Lactente , Nervo Mediano/fisiopatologia , Degeneração Neural , Nervo Fibular/fisiopatologia , Transmissão Sináptica , Doença de Tay-Sachs/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA